InterferOX
Interferon-based Therapy Against Viral And Bacterial Infections In Cattle
InterferOX is the only one on the global market that gives both treatment and prevention of both viral and bacterial infections in cattle. The active substance is interferon, a species-specific protein. Interferon kick-starts the immune system and interferon drugs for humans exist already for the treatment of Hepatitis C and HIV. InterferOX, our interferon-based product for animals, is developed to greatly reduce the use of antibiotics in cattle.
SalmoFeron
Interferon-based Therapy Against Viral And Bacterial Infections In Salmon
Our product SalmoFeron, with a unique composition of species-specific interferons, is the only one on the global market that gives both treatment and prevention of both viral and bacterial infection in salmon. SalmoFeron is a comprehensive formulation of an immune-boosting feed supplement based on species-specific (salmon) interferons tailored to all needs of fish.
SalmoFeron can both treat and prevent viral and microbial infections in salmonidae (rainbow trout and salmon) which will benefit the farmers who are forced to minimize the use of antibiotics in accordance with the governmental laws implemented due to the high risk of developing antibiotic resistance. The aquaculture sector today contributes to increasing antimicrobial resistance (AMR) through the use of antimicrobial for therapeutic and prophylactic purposes in animals. SalmoFeron will lower the usage of antibiotics which is beneficial for the environment, climate and the usage overall will contribute to an improved food production and animal welfare with higher survival rate for the salmon populations. SalmoFeron will greatly improve the ongoing battle against reducing the usage of antibiotics we will take great measures against reducing the global threat of antibiotic resistance in aquaculture.
ArtInFOLD
We develop a publicly accessible website ArtInFOLD with an intuitive user interface, hosting the most accurate artificial intelligence (AI) based algorithm to identify Intrinsically Disordered Proteins/Regions of proteins (IDPs/IDPRs). IDPRs are capable of changing the structure and imparting flexibility and adaptability to proteins, allowing them to interact with various molecules. IDPRs exhibit a high degree of dynamism and variability, making their experimental investigation challenging. However, predicting such regions can be a useful tool for developing new drugs, since IDPRs are implicated in pathologies such as viral diseases, oncology and neurodegenerative diseases among others. Testing proteins for the ability to change their structure at the in-silico drug design phase will prevent the inclusion of unpromising drug candidates in subsequent experimental work, significantly increasing the likelihood of success in drug development.